PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9086350

[Bladder carcinoma presenting with hypercalcemia: a case report].

Y Maeda·H Nakazawa·N Yoshimura·H Okuda·T Oshima·F Ito·S Onitsuka·T Kihara·N Goya·H Toma
View original source ↗Export metadata ↓

Abstract

A 47-year old woman was referred to our hospital with nausea, vomiting and the loss of body weight. Pelvic computed tomography and magnetic resonance imaging revealed an invasive bladder tumor on the left lateral wall, accompanied with calcification. Laboratory examination revealed marked hypercalcemia (20.6 mg/dl) and elevated serum parathyroid hormone-related protein-intact (29.9 pmol/l), which was apparently produced by the tumor. Treatment with pamidronate and colloid infusion resulted in normocalcemia. Anterior pelvic exenteration was performed. Histopathological diagnosis was transitional cell carcinoma > adenocarcinoma, G3, pT4pN2M0, stage IV. She died of cancer 7 months postoperatively.

Explore related subjects

Carcinoma, Transitional CellFemaleHumansHypercalcemiaMiddle AgedParathyroid Hormone-Related ProteinProtein BiosynthesisProteinsUrinary Bladder NeoplasmsCase ReportsEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Y Maeda, H Nakazawa, N Yoshimura, H Okuda, T Oshima, F Ito, S Onitsuka, T Kihara, N Goya, H Toma. 1997. [Bladder carcinoma presenting with hypercalcemia: a case report].. https://pubmed.ncbi.nlm.nih.gov/9086350/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Trimodality treatment and selective organ preservation for bladder cancer.

Standard treatment for muscle-invasive bladder cancer is cystectomy. Trimodality treatment, including transurethral resection of the bladder tumor (TURBT), radiation therapy and chemotherapy, has been shown to produce survival rates comparable to those of cystectomy. With these programs, cystectomy has been reserved for patients with incomplete response or local relapse. During the past 15 years, organ preservation by trimodality treatment has been investigated in prospective series from single centers and cooperative groups, with more than 1,000 patients included. Five-year overall survival rates in the range of 50% to 60% have been reported, and approximately three quarters of the surviving patients maintained their bladder. Clinical criteria helpful in determining ideal patients for bladder preservation include early tumor stage (including high-risk T1 disease), a visibly complete TURBT, and absence of ureteral obstruction. Close coordination among all disciplines is required to achieve optimal results. Future investigations will focus on (1) optimizing radiation techniques and incorporating more effective systemic chemotherapy, and (2) the proper selection of patients based on molecular makers.

Carcinoma, Transitional Cell↗